Articles mentioning Bristol-Myers Squibb Co. (BMY)

Results 11 - 20 of 780 : Previous 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for BMY

Investing | June 19, 2015

Why Bristol-Myers Squibb Co.'s Stock Could Sink

Bristol-Myers Squibb's share price has been going through the roof due to the company's emergence as a leader in the field of immuno-oncology. This big pharma's high-flying days might be numbered, however. Here's why.

Investing | May 02, 2015

Bristol-Myers Squibb Outpaces AbbVie in Hepatitis C

Bristol-Myers Squibb's hepatitis C sales topped AbbVie's in the first quarter. Is this trend set to continue?

Investing | April 28, 2015

Bristol-Myers Squibb Crushes First-Quarter Earnings: Here's Why

Bristol-Myers posts a much stronger first quarter than expected. Here's what investors need to know.

Investing | April 20, 2015

Is Bristol-Myers Squibb. Co. About to Fall Apart?

Bristol-Myers Squibb is pinning its future on a new class of drugs that could be game-changers in the fight against cancer. The Street, though, may be wildly overestimating their commercial potential. Here's why.

Investing | April 11, 2015

The Big Pharma Stock We'd Buy and Hold for the Next 20 Years

Despite the threat of patent losses, our analysts believe these Big Pharma stocks would be smart investments over the next 20 years.

Investing | April 06, 2015

Why uniQure N.V. Stock Skyrocketed Today

Shares of uniQure burst higher today. Here's why.

Investing | March 29, 2015

The Best Dividend-Paying Healthcare Stocks

These three healthcare stocks could offer the best blend of sales and dividend growth in the sector.

Investing | March 23, 2015

3 Big Pharma Stocks Wall Street Is Wrong About

Three contributors weigh in.

Investing | March 17, 2015

Bristol-Myers Squibb Co. Is Back in the Hepatitis C Race

Bristol-Myers Squibb is pursuing FDA approval that would allow its daclatasvir to be used alongside Sovaldi in genotype 3 patients.

Investing | March 12, 2015

Better Dividend Stock: Pfizer Inc. vs. Bristol-Myers Squibb Co.

Pfizer and Bristol-Myers Squibb are two top dividend stocks. Which one offers the better investing opportunity going forward?

Results 11 - 20 of 780 : Previous 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for BMY